MBiotech Program News
04/07/2012 - 14:00 -
MBiotech Celebrates 10 Years of Success
On Thursday, June 7, 2012, the Master of Biotechnology Program at the University of Toronto Mississauga celebrated 10 years of successful graduates at a gala event on campus. This event brought together over 150 alumni from 2003-2011, along with dozens of current students, faculty, staff and industry partners.
Industry partnership awards were...
10/04/2012 - 14:00 -
Congratulations to Ilia Tikhomirov, Class of 2007
Ilia Tikhomirov, President and CEO of AvidBiologics Inc., (MBiotech Class of 2007) announced on April 5 that AvidBiologics Inc. has raised Series A capital from private investors and expanded its board of directors. The funds will be used to advance the company's antibody-drug conjugate (ADC) programs into Investigational New Drug (IND)...
04/04/2012 - 14:00 -
MBiotech students shortlisted in international essay competition
A team of three Master of Biotechnology students were were recently short-listed in an international essay competition sponsored by GlaxoSmithKline.
The GSK Rare Diseases competition invited views, insights and business strategies on the subject "Rare Diseases: a sustainable model for the pharmaceutical industry." Submissions...
30/03/2012 - 09:00 -
Dr. Leigh Revers presents to the European Association of Hospital Pharmacists
On Thursday, March 22, Dr. Leigh Revers, Associate Director of the Master of Biotechnology Program, presented to the European Association of Hospital Pharmacists Symposium in Milan, Italy. The title of his talk was "Monocolonal antibodies: What makes them unique?"
15/03/2012 - 10:00 -
MBiotech Team Places 2nd in Venture Capital Competition
Students from the Master of Biotechnology Program have once again produced outstanding results in the latest Venture Capital & Innovation Competition (VCIC), placing second against Rotman MBA teams. VCIC is the world’s premiere educational strategy competition for venture-minded and entrepreneurial MBA students in which the goal is...